Shang Hai Zheng Quan Bao·2025-06-27 20:33Core Viewpoint - Shanghai Haixin Group Co., Ltd. has successfully completed the transfer of 51.3249% equity in Shanghai Haixin Pharmaceutical Co., Ltd. to Chongqing Huisheng Yunjian Business Information Consulting Center for a total consideration of 23.0494 million yuan [2][3]. Group 1: Transaction Overview - The board of directors approved the equity transfer on September 25, 2023, and authorized the management to handle the transaction [3]. - The total transaction price for the equity transfer was set at 23.0494 million yuan [3]. - As of the announcement date, Haixin Asset has received a total of 21.8969 million yuan from Huisheng Yunjian, which accounts for 95% of the agreed transfer price [3]. Group 2: Payment Progress - The third payment of 1.1525 million yuan was recently received, completing the total payment for the equity transfer [4]. - The total amount received from Huisheng Yunjian for the equity transfer is now 23.0494 million yuan, marking the full recovery of the transfer price [4].